Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Givlaari 189 mg/mL solution for injection {equilateral_black_triangle}

Active Ingredient:
givosiran sodium
Company:  
Alnylam UK Ltd See contact details
ATC code: 
A16AX16
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL)
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 26 Oct 2022

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

{pdf} View or print the patient leaflet as PDF
Alnylam UK Ltd
Company image
Address
Point, 27 Market Street, Maidenhead, SL6 8AA, UK
Medical Information Direct Line
(Freephone) 0800 141 2569
Medical Information Direct Line
+44 (0) 1628 878 592
Medical Information e-mail
[email protected]
WWW
https://alnylam.co.uk/